Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.

The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.

Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider's series D round.

Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.

Alexandria Venture Investments was among the participants in a series B round for Wugen, which is developing cellular therapeutics for cancer.

SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.

Patient Square Capital led a series B round for the gene therapy developer that included existing corporate investor Dexcel Pharma.

Takeda Ventures has brought on Mann as a senior partner who draws on extensive life sciences-focused venture capital experience.

Klaff Realty was among the investors in the construction technology developer’s latest round, which took its overall funding to $100m.

University and diversity-focused recruitment group Yello is merging with its corporate-backed counterpart in a bid to drive DEI hiring strategy.